AZD-1222
UNII B5S3K2V0G8

Substance Identification & Data

This profile provides standardized clinical and technical data for Azd-1222, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B5S3K2V0G8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2420395-83-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B5S3K2V0G8

CAS Registry Number

2420395-83-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AZD-1222

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173021

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Azd-1222. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CHADOX1 NCOV-19

CHADOX1-S (RECOMBINANT) (AZD1222)

OXFORD-ASTRAZENECA COVID VACCINE

Brand / Trade Names

COVISHIELD

VAXZEVRIA

Systematic Nomenclature

DNA (RECOMBINANT SIMIAN ADENOVIRUS OX1 .DELTA.E1E3 VECTOR HUMAN CYTOMEGALOVIRUS PROMOTER PLUS HUMAN TISSUE PLASMINOGEN ACTIVATOR SIGNAL PEPTIDE FUSION PROTEIN WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ISOLATE WUHAN-HU-1 SPIKE GLYCOPROTEIN CODON OPTIMIZED SPECIFYING)

SYS